OS Therapies (NYSE:OSTX) Earns Buy Rating from Analysts at Lake Street Capital
Lake Street Capital initiated coverage on shares of OS Therapies (NYSE:OSTX – Free Report) in a research report released on Wednesday, Marketbeat.com reports. The brokerage issued a buy rating and a $19.00 price target on the stock. OSTX has been the topic of several other research reports. Maxim Group lifted their target price on OS […]
